MERCK SHARP & DOHME LLC Federal Contracts — Government Award History
Total (All Time)$8.4B
Latest FY$835,519
Primary AgencyDepartment of Veterans Affairs
MERCK SHARP & DOHME LLC has received $8.4B in total federal contract awards
across 9 fiscal year(s). ▼ 50.7% vs FY2025 Peak year was FY2014 ($3.1B).
Primary awarding agency: Department of Veterans Affairs.
Data covers largest contracts by award amount. Source: USASpending.gov (FPDS).
Awards by Fiscal Year
| Year | Spending | Total | Contracts | Top Agency |
|---|---|---|---|---|
| FY2026 | $835,519 | 18건 | Department of Veterans Affairs | |
| FY2025 | $1.7M | 32건 | Department of Veterans Affairs | |
| FY2024 | $153.8M | 13건 | Department of Health and Human Services | |
| FY2022 | $221,955 | 10건 | Department of Defense | |
| FY2021 | $2307.8M | 7건 | Department of Defense | |
| FY2017 | $2575.5M | 10건 | Department of Health and Human Services | |
| FY2016 | $134.3M | 4건 | Department of Health and Human Services | |
| FY2015 | $90.1M | 16건 | Department of Health and Human Services | |
| FY2014 | $3095.6M | 3건 | Department of Health and Human Services |
Notable Contracts
| Date | Agency | Amount | Description |
|---|---|---|---|
| 2014-04-01 | Department of Health and Human Services | $3001.0M | VSCCINE FOR CHILDREN (VFC) 2014 |
| 2017-04-01 | Department of Health and Human Services | $2296.3M | IGF::OT::IGF 2017 VACCINES FOR CHILDREN |
| 2021-06-07 | Department of Defense | $2205.0M | COVID-19 ORAL ANTIVIRAL MK-4482 (MOLNUPIRAVIR) |
| 2013-04-01 | Department of Health and Human Services | $1372.6M | VACCINE FOR CHILDREN 2013 |
| 2017-09-28 | Department of Health and Human Services | $203.3M | IGF::OT::IGF |
| 2024-09-30 | Department of Health and Human Services | $153.0M | ERVEBO PROCUREMENT |
| 2021-03-01 | Department of Health and Human Services | $102.3M | ADDRESSING THE COVID-19 PANDEMIC: URGENT PRIORITIES |
| 2014-07-01 | Department of Health and Human Services | $94.5M | VACCINES FOR ADULTS 2014 |
| 2013-07-01 | Department of Health and Human Services | $93.7M | VACCINE FOR ADULT 2013 |
| 2014-12-19 | Department of Health and Human Services | $77.9M | IGF::OT::IGF FOR OTHER FUNCTIONS |
| 2017-07-01 | Department of Health and Human Services | $75.3M | 2017 ADULT VACCINES |
| 2016-07-01 | Department of Health and Human Services | $68.3M | IGF::OT::IGF 2016 VFA – MERCK |
| 2016-08-29 | Department of Health and Human Services | $65.3M | BPS – ADVANCE THE DEVELOPMENT OF V920, A VACCINE AGAINST EBOLA VIRUS USING A REC |
| 2015-09-09 | Department of Defense | $8.4M | IGF::OT::IGF BASE PERIOD – PSC: AN12 |
| 2015-01-15 | Department of Health and Human Services | $600,845 | MERCK VACCINES FOR FOH |
| 2015-09-14 | Department of Health and Human Services | $507,482 | MERCK VACCINES FOR STOCK |
| 2015-02-13 | Department of Health and Human Services | $465,022 | PHARMACEUTICALS MAIN |
| 2015-10-08 | Department of Health and Human Services | $432,066 | VACCINES FOR STOCK |
| 2026-06-01 | Department of Veterans Affairs | $342,254 | WINREVAIR 45MG/VIAL INJ,LYPHL |
| 2015-03-26 | Department of Health and Human Services | $334,019 | MERCK VACCINES FOR STOCK |